185 related articles for article (PubMed ID: 24896364)
21. The neuroprotective mechanism of erythropoietin-TAT fusion protein against neurodegeneration from ischemic brain injury.
Liu P; Liu X; Liou AK; Xing J; Jing Z; Ji X; Liu X; Zhao H; Yan F; Chen J; Cao G; Luo Y
CNS Neurol Disord Drug Targets; 2014; 13(8):1465-74. PubMed ID: 25106625
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
Rosenberg EC; Patra PH; Whalley BJ
Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
[TBL] [Abstract][Full Text] [Related]
23. Erythropoietin improves histological and functional outcomes after traumatic brain injury in mice in the absence of the neural erythropoietin receptor.
Xiong Y; Mahmood A; Qu C; Kazmi H; Zhang ZG; Noguchi CT; Schallert T; Chopp M
J Neurotrauma; 2010 Jan; 27(1):205-15. PubMed ID: 19715391
[TBL] [Abstract][Full Text] [Related]
24. Erythropoietin for neonatal brain injury: opportunity and challenge.
Xiong T; Qu Y; Mu D; Ferriero D
Int J Dev Neurosci; 2011 Oct; 29(6):583-91. PubMed ID: 21277366
[TBL] [Abstract][Full Text] [Related]
25. Erythropoietin and the brain: from neurodevelopment to neuroprotection.
Buemi M; Cavallaro E; Floccari F; Sturiale A; Aloisi C; Trimarchi M; Grasso G; Corica F; Frisina N
Clin Sci (Lond); 2002 Sep; 103(3):275-82. PubMed ID: 12193153
[TBL] [Abstract][Full Text] [Related]
26. Erythropoietin (epoetin) as a protective factor for the brain.
Malhotra S; Nijhawan S; Rosenbaum DM
Curr Atheroscler Rep; 2004 Jul; 6(4):301-6. PubMed ID: 15191705
[TBL] [Abstract][Full Text] [Related]
27. Neuroprotective potential of erythropoietin and its derivative carbamylated erythropoietin in periventricular leukomalacia.
Liu W; Shen Y; Plane JM; Pleasure DE; Deng W
Exp Neurol; 2011 Aug; 230(2):227-39. PubMed ID: 21596035
[TBL] [Abstract][Full Text] [Related]
28. Impact of inhibition of erythropoietin treatment-mediated neurogenesis in the dentate gyrus of the hippocampus on restoration of spatial learning after traumatic brain injury.
Zhang Y; Chopp M; Mahmood A; Meng Y; Qu C; Xiong Y
Exp Neurol; 2012 May; 235(1):336-44. PubMed ID: 22414310
[TBL] [Abstract][Full Text] [Related]
29. Intranasal formulation of erythropoietin (EPO) showed potent protective activity against amyloid toxicity in the Aβ₂₅₋₃₅ non-transgenic mouse model of Alzheimer's disease.
Maurice T; Mustafa MH; Desrumaux C; Keller E; Naert G; de la C García-Barceló M; Rodríguez Cruz Y; Garcia Rodríguez JC
J Psychopharmacol; 2013 Nov; 27(11):1044-57. PubMed ID: 23813967
[TBL] [Abstract][Full Text] [Related]
30. EPO-dependent activation of PI3K/Akt/FoxO3a signalling mediates neuroprotection in in vitro and in vivo models of Parkinson's disease.
Jia Y; Mo SJ; Feng QQ; Zhan ML; OuYang LS; Chen JC; Ma YX; Wu JJ; Lei WL
J Mol Neurosci; 2014 May; 53(1):117-24. PubMed ID: 24390959
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of klotho and erythropoietin contributes to the neuroprotection induced by curcumin-loaded nanoparticles in experimental model of chronic epilepsy.
Mansoor SR; Hashemian M; Khalili-Fomeshi M; Ashrafpour M; Moghadamnia AA; Ghasemi-Kasman M
Brain Res Bull; 2018 Sep; 142():281-288. PubMed ID: 30130550
[TBL] [Abstract][Full Text] [Related]
32. Systematic Review of Erythropoietin (EPO) for Neuroprotection in Human Studies.
Hemani S; Lane O; Agarwal S; Yu SP; Woodbury A
Neurochem Res; 2021 Apr; 46(4):732-739. PubMed ID: 33521906
[TBL] [Abstract][Full Text] [Related]
33. The non-haematopoietic biological effects of erythropoietin.
Arcasoy MO
Br J Haematol; 2008 Apr; 141(1):14-31. PubMed ID: 18324962
[TBL] [Abstract][Full Text] [Related]
34. Continuous intraventricular infusion of erythropoietin exerts neuroprotective/rescue effects upon Parkinson's disease model of rats with enhanced neurogenesis.
Kadota T; Shingo T; Yasuhara T; Tajiri N; Kondo A; Morimoto T; Yuan WJ; Wang F; Baba T; Tokunaga K; Miyoshi Y; Date I
Brain Res; 2009 Feb; 1254():120-7. PubMed ID: 19101524
[TBL] [Abstract][Full Text] [Related]
35. Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion.
Ratilal BO; Arroja MM; Rocha JP; Fernandes AM; Barateiro AP; Brites DM; Pinto RM; Sepodes BM; Mota-Filipe HD
J Neurosurg; 2014 Jul; 121(1):55-62. PubMed ID: 24702327
[TBL] [Abstract][Full Text] [Related]
36. Erythropoietin in neonatal brain protection: the past, the present and the future.
Kumral A; Tüzün F; Oner MG; Genç S; Duman N; Ozkan H
Brain Dev; 2011 Sep; 33(8):632-43. PubMed ID: 21109375
[TBL] [Abstract][Full Text] [Related]
37. Letter: Antiepileptogenic and neuroprotective effects of erythropoietin: recent data.
Mikati MA; Mohler Cornett KM
Epilepsia; 2009 Jun; 50(6):1654-5. PubMed ID: 19646143
[No Abstract] [Full Text] [Related]
38. Erythropoietin and the nervous system.
Genc S; Koroglu TF; Genc K
Brain Res; 2004 Mar; 1000(1-2):19-31. PubMed ID: 15053948
[TBL] [Abstract][Full Text] [Related]
39. Activation of migration of endogenous stem cells by erythropoietin as potential rescue for neurodegenerative diseases.
Khairallah MI; Kassem LA; Yassin NA; Gamal el Din MA; Zekri M; Attia M
Brain Res Bull; 2016 Mar; 121():148-57. PubMed ID: 26802509
[TBL] [Abstract][Full Text] [Related]
40. Epileptogenesis in the immature brain: emerging mechanisms.
Rakhade SN; Jensen FE
Nat Rev Neurol; 2009 Jul; 5(7):380-91. PubMed ID: 19578345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
